Deutsche Bank Aktiengesellschaft Analysts Give Gerresheimer (ETR:GXI) a €112.00 Price Target

Deutsche Bank Aktiengesellschaft set a €112.00 ($131.76) price objective on Gerresheimer (ETR:GXI) in a research report sent to investors on Friday, Borsen Zeitung reports.

Several other brokerages have also issued reports on GXI. The Goldman Sachs Group set a €111.00 ($130.59) target price on shares of Gerresheimer in a research report on Wednesday, August 11th. Credit Suisse Group set a €106.00 ($124.71) target price on shares of Gerresheimer in a research report on Wednesday, July 14th. Berenberg Bank set a €109.00 ($128.24) target price on shares of Gerresheimer in a research report on Monday, July 19th. DZ Bank restated a buy rating on shares of Gerresheimer in a research report on Wednesday, May 26th. Finally, JPMorgan Chase & Co. set a €92.50 ($108.82) price target on shares of Gerresheimer in a research report on Tuesday, July 13th. Two analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of Hold and a consensus target price of €100.07 ($117.73).

GXI opened at €85.55 ($100.65) on Friday. Gerresheimer has a 52-week low of €81.30 ($95.65) and a 52-week high of €103.70 ($122.00). The business’s 50-day simple moving average is €88.66 and its 200 day simple moving average is €89.21. The firm has a market capitalization of $2.69 billion and a PE ratio of 28.57. The company has a debt-to-equity ratio of 122.13, a quick ratio of 0.59 and a current ratio of 0.98.

About Gerresheimer

Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices.

Featured Article: What is the price-sales ratio?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.